Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Billions.
The item "Total-Cashflows-From-Investing-Activities" stands at 6.96 Billion Euros for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 12/31/2020.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 13.50 Billion Euros compared to the value the year prior.
The 1 year change is 13.50 Billion Euros.
The 3 year change is 13.38 Billion Euros.
The 5 year change is -0.218 Billion Euros.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Cashflows From Investing Activities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Cashflows From Investing Activities | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Cashflows From Investing Activities | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Cashflows From Investing Activities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Cashflows From Investing Activities | 280,205,508,085.11 |